JAAD Game Changer: "High-Dose, High-Frequency Infliximab: A Novel Treatment Paradigm for Hidradenitis Suppurativa".

High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativaJournal of the American Academy of DermatologyVol. 82Issue 5PreviewThe permanent disfigurement associated with hidradenitis suppurativa (HS) necessitates early aggressive disease intervention. Although limited data support the use of infliximab (IFX) in HS, the efficacy of high-dose, high-frequency IFX has yet to be defined. Full-Text PDF